Cargando…

Simvastatin is a potential candidate drug in ovarian clear cell carcinomas

Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking efficient treatment options. Based on previous studies, we assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arildsen, Nicolai Skovbjerg, Hedenfalk, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546754/ https://www.ncbi.nlm.nih.gov/pubmed/33088426 http://dx.doi.org/10.18632/oncotarget.27747

Ejemplares similares

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2017)

Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival()()
por: Jönsson, Jenny-Maria, et al.
Publicado: (2015)

PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
por: Martin de la Fuente, Laura, et al.
Publicado: (2020)

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
por: Arildsen, Nicolai Skovbjerg, et al.
Publicado: (2019)

Crizotinib and PARP inhibitors act synergistically by triggering apoptosis in high-grade serous ovarian cancer
por: Sahin, Irem Durmaz, et al.
Publicado: (2019)

Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma
por: Akiya, Masashi, et al.
Publicado: (2017)

The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer
por: Johansson, Ida, et al.
Publicado: (2013)

Identification of potential key genes associated with ovarian clear cell carcinoma
por: Xu, Youzheng, et al.
Publicado: (2018)

Tumoricidal Activity of Simvastatin in Synergy with RhoA Inactivation in Antimigration of Clear Cell Renal Cell Carcinoma Cells
por: Lee, Yuan-Chii Gladys, et al.
Publicado: (2023)

Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis
por: Ortega, Israel, et al.
Publicado: (2014)

Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma
por: Aihemaiti, Gulinisha, et al.
Publicado: (2018)

In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection
por: Gjetting, Torben, et al.
Publicado: (2010)

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
por: Makii, Chinami, et al.
Publicado: (2016)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
por: Arakawa, Noriaki, et al.
Publicado: (2016)

Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology
por: Meng, Zhuo, et al.
Publicado: (2023)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Identification of potential key genes associated with ovarian clear cell carcinoma [Retraction]
Publicado: (2019)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients
por: Liu, Puyu, et al.
Publicado: (2023)

Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013)

Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma
por: Hsu, I-Ling, et al.
Publicado: (2016)

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
por: Tan, Tuan Zea, et al.
Publicado: (2019)

Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
por: Amano, Yasuaki, et al.
Publicado: (2015)

Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
por: Matsuzaki, Shinya, et al.
Publicado: (2015)

Clear cell ovarian cancer and endometriosis: is there a relationship?
por: Szubert, Maria, et al.
Publicado: (2016)

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
por: Li, Xiangyu, et al.
Publicado: (2022)

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
por: Saini, Uksha, et al.
Publicado: (2022)

Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma
por: Wang, Wei, et al.
Publicado: (2015)

Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma
por: Suzuki, Kazuhiro, et al.
Publicado: (2022)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

Simvastatin Is Effective in Killing the Radioresistant Breast Carcinoma Cells
por: Aschenbrenner, Bertram, et al.
Publicado: (2021)

Inhibitory effect of simvastatin in nasopharyngeal carcinoma cells
por: Ma, Zhaoxin, et al.
Publicado: (2019)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015)

Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
por: Luo, Yongwen, et al.
Publicado: (2019)

Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
por: Thangamani, Shankar, et al.
Publicado: (2015)

Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target
por: Tsang, Tsun Yee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nppv3t1mln0bkcdaq7jqclava3